MIR216A

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MIR216A mutation is significantly associated with the RNA expression of many other genes, with 11 significant associations in total. SKCM shows the largest number of these associations.

The most reproducible MIR216A-associated genes across cancer lineages are CDY7P, RPL31P59, and MIR3162. Each is linked with MIR216A in more than 1 cancer types. Because this analysis shows association rather than direction, both MIR216A-to-partner and partner-to-MIR216A results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MIR216A→partner) and Y-score (partner→MIR216A) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SKCMCDY7P →+0.034+5.292<.001.00631
SKCMRPL31P59 →+0.155+5.680<.001.00331
UCECMIR3162 →+0.860+5.081<.001.00831
SKCMLINC02353 →+0.164+5.037<.001.00931
SKCMOR7E16P →+0.064+5.867<.001.00331
SKCMOR13H1 →+0.056+5.680<.001.00331
Each partner links to its Q-omics profile. Showing the 6 strongest of 11 associations by consensus.

Exploration